Last update :
18/04/2024
References   References 1516  
Type : Manufacturer

Research teams :
Authors :
Title : Ropivacaine (Naropeine®) - Summary of Product Characteristics
Reference : Mercury Pharmaceuticals Limited 2012

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionClonidine hydrochloride Antihypertensive
Compatible 0,005 >> 0,05 mg/ml + InjectionRopivacain hydrochloride 1 - 2 mg/ml
InjectionFentanyl citrate Analgesic
Compatible 1 >> 10 µg/ml + InjectionRopivacain hydrochloride 1 - 2 mg/ml
InjectionMorphine sulfate Analgesic
Compatible 0,02 >> 0,1 mg/ml + InjectionRopivacain hydrochloride 1 - 2 mg/ml
InjectionRopivacain hydrochloride Local anesthetic
Factors which affect stability PH PH > 6 Induces Degradation
Compatible 1 - 2 mg/ml + InjectionClonidine hydrochloride 0,005 >> 0,05 mg/ml
Compatible 1 - 2 mg/ml + InjectionFentanyl citrate 1 >> 10 µg/ml
Compatible 1 - 2 mg/ml + InjectionMorphine sulfate 0,02 >> 0,1 mg/ml
Compatible 1 - 2 mg/ml + InjectionSufentanil citrate 0,0004 >> 0,004 mg/ml
InjectionSufentanil citrate Analgesic
Compatible 0,0004 >> 0,004 mg/ml + InjectionRopivacain hydrochloride 1 - 2 mg/ml

  Mentions Légales